Duloxetine | (S)-Duloxetine | Serotonin-norepinephrine Reuptake Inhibitor

规格	价格	会员价	库存	数量
{[ item.pr_size ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]}	{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]}	现货	咨询	- +

临床研究

NCT号	适应症或疾病	临床期	招募状态	预计完成时间	地点

NCT00190645	Stress Urinary Incontinence	Phase 3	Completed	-	United States, Colorado ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician Denver, Colorado, United States, 80220 Canada, Ontario For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559,1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician Oakville, Ontario, Canada, L6H3P1 收起 <<
NCT00387413	Hyperalgesia	Phase 1	Completed	-	United Kingdom ... 展开 >> GSK Investigational Site Cambridge, Cambridgeshire, United Kingdom, CB2 0QQ 收起 <<
NCT00945945	Osteoarthritis Knee Pain	Phase 3	Completed	-	-
NCT00945945	-		Completed	-	-
NCT02174822	Drug-drug Interaction	Phase 1	Completed	-	Australia, Victoria ... 展开 >> Nucleus Network Melbourne, Victoria, Australia, 3004 收起 <<
NCT00190632	Stress Urinary Incontinence	Phase 3	Completed	-	United States, Ohio ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician Cleveland, Ohio, United States, 44122 收起 <<
NCT00532480	Major Depression	Phase 4	Completed	-	United States, Indiana ... 展开 >> Indiana University Adult Psychiatric Clinic Indianapolis, Indiana, United States, 46202 收起 <<
NCT00191204	Urinary Incontinence Stress	Phase 3	Completed	-	United Kingdom ... 展开 >> For additional information regarding investigative sites for this trial contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours EST), or speak with your personal physician. Peterborough, United Kingdom, PE3 6JG 收起 <<
NCT00609557	Osteoarthritis ... 展开 >> Pain 收起 <<	Phase 4	Completed	-	-
NCT03364075	Low Back Pain	Phase 2	Terminated(Recruitment issue)	-	Canada, Quebec ... 展开 >> Centre for Innovative Medicine - McGill University Health Centre Montréal, Quebec, Canada, H4A 3J1 收起 <<
NCT00191087	Urinary Incontinence, Stress	Phase 3	Completed	-	United Kingdom ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon- Fri from 9AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. London, England, United Kingdom, SE3 7UQ 收起 <<
NCT00424593	Back Pain Without Radiation	Phase 3	Completed	-	Brazil ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your p Curitiba, Brazil, 80060240 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your p San Paulo, Brazil, 04027-000 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your p Sao Paulo, Brazil, 04026-000 France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your p Amiens, France, 80054 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your p Marseille, France, 13008 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your p Paris, France, 75014 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your p Saint Affrique, France, 12400 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your p Saint-Etienne, France, 42055 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your p Ellwangen, Germany, 73479 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your p Graefelfing, Germany, 82166 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your p Hamburg, Germany, 22143 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your p Wiesbaden, Germany, 65191 Mexico For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your p Mexico City, Mexico, 06700 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your p Monterrey, Mexico, 64460 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your p San Pedro Garza Garcia, Mexico, 66260 Netherlands For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your p Amsterdam, Netherlands, 1105 AZ For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your p Rotterdam, Netherlands, 3039 BD 收起 <<
NCT00424593	-		Completed	-	-
NCT00408876	Back Pain Without Radiation	Phase 3	Completed	-	United States, Florida ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Fort Myers, Florida, United States, 33912 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Orlando, Florida, United States, 32806 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph South Miami, Florida, United States, 33143 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Tampa, Florida, United States, 33606 收起 <<
NCT00191685	Depressive Disorder, Major	Phase 3	Completed	-	Australia, New South Wales ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time(UTC/GMT - 5 hours, EST), or speak with your personal physician. Paddington, New South Wales, Australia Australia, Queensland For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time(UTC/GMT - 5 hours, EST), or speak with your personal physician. Everton Park, Queensland, Australia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time(UTC/GMT - 5 hours, EST), or speak with your personal physician. Hoppers Crossing, Queensland, Australia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time(UTC/GMT - 5 hours, EST), or speak with your personal physician. Nambour, Queensland, Australia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time(UTC/GMT - 5 hours, EST), or speak with your personal physician. New Farm, Queensland, Australia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time(UTC/GMT - 5 hours, EST), or speak with your personal physician. South Port BC, Queensland, Australia Australia, South Australia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time(UTC/GMT - 5 hours, EST), or speak with your personal physician. Elizabeth Vale, South Australia, Australia Australia, Victoria For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time(UTC/GMT - 5 hours, EST), or speak with your personal physician. Richmond, Victoria, Australia Canada, Alberta For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time(UTC/GMT - 5 hours, EST), or speak with your personal physician. Calgary, Alberta, Canada For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time(UTC/GMT - 5 hours, EST), or speak with your personal physician. Edmonton, Alberta, Canada Canada, British Columbia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time(UTC/GMT - 5 hours, EST), or speak with your personal physician. Vancouver, British Columbia, Canada Canada, Manitoba For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time(UTC/GMT - 5 hours, EST), or speak with your personal physician. Winnipeg, Manitoba, Canada Canada, New Brunswick For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time(UTC/GMT - 5 hours, EST), or speak with your personal physician. St. John, New Brunswick, Canada Canada, Nova Scotia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time(UTC/GMT - 5 hours, EST), or speak with your personal physician. Halifax, Nova Scotia, Canada For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time(UTC/GMT - 5 hours, EST), or speak with your personal physician. Sydney, Nova Scotia, Canada Canada, Ontario For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time(UTC/GMT - 5 hours, EST), or speak with your personal physician. Kingston, Ontario, Canada For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time(UTC/GMT - 5 hours, EST), or speak with your personal physician. London, Ontario, Canada For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time(UTC/GMT - 5 hours, EST), or speak with your personal physician. Mississauga, Ontario, Canada For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time(UTC/GMT - 5 hours, EST), or speak with your personal physician. Sudbury, Ontario, Canada For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time(UTC/GMT - 5 hours, EST), or speak with your personal physician. Toronto, Ontario, Canada Canada, Quebec For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time(UTC/GMT - 5 hours, EST), or speak with your personal physician. Beauport, Quebec, Canada For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time(UTC/GMT - 5 hours, EST), or speak with your personal physician. Montreal, Quebec, Canada For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time(UTC/GMT - 5 hours, EST), or speak with your personal physician. Quebec City, Quebec, Canada 收起 <<
NCT02443194	Depression	Phase 3	Terminated(principle investiga... 展开 >>tor decision due to many adverse events in patients) 收起 <<	-	-
NCT00491348	Worry Anxiety	Not Applicable	Terminated(Change of MRI mode)	-	Taiwan ... 展开 >> National Taiwan University Hospital Taipei, Taiwan 收起 <<
NCT00583193	Posttraumatic Stress Disorders	Phase 3	Unknown	June 2008	United States, New Mexico ... 展开 >> New Mexico VA Health Care System Recruiting Albuquerque, New Mexico, United States, 87108 Principal Investigator: Jose M Canive, M.D. 收起 <<
NCT00517985	Major Depressive Disorder	Phase 4	Completed	-	United States, Arizona ... 展开 >> Women's Mental Health Program; University of Arizona; Department of Psychiatry Tucson, Arizona, United States, 85724 收起 <<
NCT01118780	Generalized Anxiety Disorder	Phase 4	Completed	-	-
NCT00803361	Generalized Anxiety Disorder	Phase 3	Completed	-	China ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China, 100088 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guang Zhou, China, 510370 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hangzhou, China, 310009 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kunming, China, 650032 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nanjing, China, 210029 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shanghai, China, 200065 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Xi'An, China, 710032 收起 <<
NCT02229825	Depressive Disorder, Major	Phase 4	Completed	-	-
NCT00408876	-		Completed	-	-
NCT00607789	Binge Eating ... 展开 >>Depression 收起 <<	Phase 4	Completed	-	United States, Ohio ... 展开 >> University of Cincinnati and Lindner Center of HOPE Cincinnati, Ohio, United States, 45219 收起 <<
NCT01118780	-		Completed	-	-
NCT00607789	-		Completed	-	-
NCT00532480	-		Completed	-	-
NCT00406848	Major Depressive Disorder	Phase 4	Completed	-	-
NCT00673452	Fibromyalgia	Phase 4	Completed	-	-
NCT00803361	-		Completed	-	-
NCT00673452	-		Completed	-	-
NCT00114127	Anxiety Disorder	Phase 3	Completed	-	United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 收起 <<
NCT00406848	-		Completed	-	-
NCT00755807	-		Completed	-	-
NCT01000805	Major Depressive Disorder	Phase 4	Completed	-	-
NCT00755807	Multiple Sclerosis	Phase 3	Completed	-	-
NCT00114127	-		Completed	-	-
NCT01000805	-		Completed	-	-
NCT00385671	Diabetic Neuropathy, Painful	Phase 4	Completed	-	United States, California ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Torrance, California, United States, 90503 United States, Connecticut For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cromwell, Connecticut, United States, 06416 United States, New York For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Staten Island, New York, United States, 10312 United States, North Carolina For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Greenville, North Carolina, United States, 27834 United States, Utah For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Midvale, Utah, United States, 84047 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bochum, Germany, D-44805 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dresden, Germany, 01307 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamburg, Germany, 20354 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Siegen, Germany, 57072 收起 <<
NCT01035073	Major Depressive Disorder ... 展开 >> Soft Tissue Discomfort Syndrome Pain 收起 <<	Phase 4	Completed	-	United States, Pennsylvania ... 展开 >> Depression Research Unit, University of Pennsylvania School of Medicine Philadelphia, Pennsylvania, United States, 19104-3309 收起 <<
NCT00401258	Irritable Bowel Syndrome	Phase 4	Completed	-	United States, Massachusetts ... 展开 >> McLean Hospital Belmont, Massachusetts, United States, 02478 收起 <<
NCT00531895	Major Depression ... 展开 >> Chronic Primary Headache 收起 <<	Phase 4	Completed	-	Brazil ... 展开 >> Hospital SOCOR Belo Horizonte, MG, Brazil, 30000-000 收起 <<
NCT03560427	Acute Pain	Not Applicable	Not yet recruiting	October 2018	Egypt ... 展开 >> Diab Assiut, Assuit, Egypt, 71515 收起 <<
NCT01619566	Fibromyalgia	Phase 4	Withdrawn(Sponsor related)	-	United States, California ... 展开 >> University of California, San Diego Medical Centers San Diego, California, United States, 92103 收起 <<
NCT00385671	-		Completed	-	-
NCT00960986	Major Depressive Disorder (MDD... 展开 >>) 收起 <<	Phase 4	Completed	-	Korea, Republic of ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cheong Ju-City, Korea, Republic of, 361-711 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Goyang-Si, Korea, Republic of, 410-719 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seongnam-Si, Korea, Republic of, 463-707 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 134-791 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sungnam-Si, Korea, Republic of, 463-712 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Suwon-City, Korea, Republic of, 442-721 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Yangsan, Korea, Republic of, 626-770 收起 <<
NCT00401258	-		Completed	-	-
NCT00398632	-		Terminated(Unable to recruit s... 展开 >>ubjects) 收起 <<	-	-
NCT00960986	-		Completed	-	-
NCT00375973	-		Completed	-	-
NCT01166048	Chronic Low Back Pain	Phase 4	Completed	-	Austria ... 展开 >> Department of Special Anesthesia and Pain Therapy, Medical University of Vienna, AKH Vienna Vienna, Austria, 1090 收起 <<
NCT00552682	Fibromyalgia ... 展开 >>HIV-1 Infection 收起 <<	Phase 3	Completed	-	Spain ... 展开 >> Germans Trias i Pujol Hospital Badalona, Barcelona, Spain, 08916 收起 <<
NCT00398632	Depression	Phase 4	Terminated(Unable to recruit s... 展开 >>ubjects) 收起 <<	-	United States, California ... 展开 >> Stanford University School of Medicine Stanford, California, United States, 94305 收起 <<
NCT00981149	Temporomandibular Joint Disord... 展开 >>ers 收起 <<	Not Applicable	Completed	-	United States, Maryland ... 展开 >> University of Maryland Dental School Baltimore, Maryland, United States, 21201 收起 <<
NCT00981149	-		Completed	-	-
NCT01237587	Fibromyalgia	Phase 3	Completed	-	-
NCT00933439	Major Depressive Disorder	Not Applicable	Completed	-	United States, Texas ... 展开 >> Mood Disorders Research Program and Clinic - UT Southwestern Medical Center Dallas, Texas, United States, 75390 收起 <<
NCT00375973	Fatigue Syndrome, Chronic	Phase 2 Phase 3	Completed	-	United States, Ohio ... 展开 >> Women's Health Research Program Cincinnati, Ohio, United States, 45219 收起 <<
NCT00529789	-		Completed	-	-
NCT00529789	Major Depressive Disorder	Phase 2	Completed	-	-
NCT00331799	Major Depressive Disorder	Phase 2	Completed	-	United States, North Carolina ... 展开 >> Duke University Medical Center Durham, North Carolina, United States, 27710 收起 <<
NCT02417935	Diabetic Peripheral Neuropathi... 展开 >>c Pain 收起 <<	Phase 4	Completed	-	-
NCT01237587	-		Completed	-	-
NCT02417935	-		Completed	-	-
NCT00457730	Multiple Sclerosis	Phase 2 Phase 3	Completed	-	United States, Washington ... 展开 >> Evergreen Healthcare Kirkland, Washington, United States, 98034 收起 <<
NCT00331799	-		Completed	-	-
NCT00457730	-		Completed	-	-
NCT01148472	Major Depressive Disorder	Phase 4	Completed	-	-
NCT00322621	Diabetic Neuropathies	Phase 4	Completed	-	Brazil ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fortaleza, Brazil, 60120-020 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Porto Alegre, Brazil, 90035170 France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Angers, France, 49033 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Annecy, France, 74011 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bron, France, 69500 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dijon, France, 21079 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Narbonne, France, 11108 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nevers, France, 58000 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nice, France, 06002 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chemitz, Germany, 09111 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dresden, Germany, 01307 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mainz, Germany, D-55116 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Münster, Germany, 48145 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Schkeuditz, Germany, 04435 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Siegen, Germany, 57072 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wurzburg, Germany, 97070 Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Genova, Italy, 16132 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Perugia, Italy, 06100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rome, Italy, 00161 收起 <<
NCT00322621	-		Completed	-	-
NCT00464698	Obsessive Compulsive Disorder	Phase 4	Completed	-	United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 收起 <<
NCT00696774	Depressive Disorder, Major	Phase 4	Completed	-	Korea, Republic of ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guri City, Korea, Republic of, 471-701 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 136 705 收起 <<
NCT00437125	Major Depressive Disorder ... 展开 >> Idiopathic Parkinson Disease 收起 <<	Phase 4	Completed	-	Italy ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ancona, Italy, 60124 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Brescia, Italy, 25100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Catania, Italy, 95125 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Genova, Italy, 16132 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lido Di Camaiore, Italy, 55000 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Messina, Italy, 98122 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Milano, Italy, 20157 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Napoli, Italy, 80131 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Padova, Italy, 35100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pisa, Italy, 56100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pozzilli, Italy, 86077 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rome, Italy, 00179 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Torino, Italy, 10126 收起 <<
NCT00696774	-		Completed	-	-
NCT00438971	-		Completed	-	-
NCT00990067	Mood Disorder ... 展开 >> Substance-Related Disorders Amphetamine-Related Disorders 收起 <<	Phase 1	Completed	-	Switzerland ... 展开 >> Clinical Pharmacology & Toxicology, University Hospital Basel Basel, Switzerland, 4031 收起 <<
NCT00464698	-		Completed	-	-
NCT00360724	Dysthymic Disorder ... 展开 >> Depressive Disorder NOS 收起 <<	Phase 4	Completed	-	United States, New York ... 展开 >> New York State Psychiatric Institute New York, New York, United States, 10032 收起 <<
NCT00438971	Panic Disorder	Phase 4	Completed	-	United States, Massachusetts ... 展开 >> The Center for Anxiety and Traumatic Stress Disorders at Massachusetts General Hospital Boston, Massachusetts, United States, 02114 收起 <<
NCT01621191	Fibromyalgia	Phase 3	Completed	-	Japan ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Miyagi, Japan, 982-0032 收起 <<
NCT00617045	Postpartum Depression ... 展开 >> Major Depressive Disorder 收起 <<	Not Applicable	Withdrawn(poor patient recruit... 展开 >>ment) 收起 <<	-	United States, Connecticut ... 展开 >> Perinatal & Postpartum Research Program 142 Temple ST Suite 301 New Haven, Connecticut, United States, 06510 收起 <<
NCT00443352	Migraine	Phase 4	Completed	-	United States, Pennsylvania ... 展开 >> Jefferson Headache Center Philadelphia, Pennsylvania, United States, 19107 收起 <<
NCT00437125	-		Completed	-	-
NCT01621191	-		Completed	-	-
NCT00360724	-		Completed	-	-
NCT00443352	-		Completed	-	-
NCT03468348	Acute Pain	Not Applicable	Recruiting	August 20, 2018	Egypt ... 展开 >> Diab Recruiting Assiut, Assuit, Egypt, 71515 Contact: Diab Hetta, MD +201091090009 收起 <<
NCT00933452	Healthy	Phase 1	Completed	-	China, Shanghai ... 展开 >> Shanghai Mental Health Center Shanghai, Shanghai, China, 200030 收起 <<
NCT00989157	Bariatric Surgery	Phase 3	Completed	-	United States, North Dakota ... 展开 >> Neuropsychiatric Research Institute Fargo, North Dakota, United States, 58103 收起 <<
NCT00989157	-		Completed	-	-
NCT01855919	Back Pain Lower Back Chronic	Phase 3	Completed	-	Japan ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Saitama, Japan 收起 <<
NCT00763178	Posttraumatic Stress Disorder	Early Phase 1	Completed	-	United States, Connecticut ... 展开 >> VA Connecticut Healthcare System West Haven, Connecticut, United States, 06516 收起 <<
NCT00533026	Anticoagulant Effect of Warfar... 展开 >>in When Taken With Duloxetine. 收起 <<	Phase 1	Completed	-	United Kingdom ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559), Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician Leeds, West Yorkshire, United Kingdom 收起 <<
NCT03548454	Chronic Pain	Phase 4	Recruiting	July 31, 2020	United States, California ... 展开 >> Stanford Pain Management Center Recruiting Redwood City, California, United States, 94063 Contact: Vafi Salmasi, MD. 650-725-0246 vsalmasi@stanford.edu 收起 <<
NCT01451606	-		Terminated(Adequate recruitmen... 展开 >>t was not achieved in the time frame allowed.) 收起 <<	-	-
NCT02248480	Osteoarthritis of the Knee	Phase 3	Completed	-	Japan ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hyogo, Japan, 651-0086 收起 <<
NCT00940693	Attention Deficit Disorder Wit... 展开 >>h Hyperactivity 收起 <<	Phase 2	Completed	-	Canada, Quebec ... 展开 >> Centre Hospitalier Universitaire de Montréal: Hôpital Notre-Dame Montreal, Quebec, Canada, H2L 4M1 收起 <<
NCT02248480	-		Completed	-	-
NCT01558700	-		Completed	-	-
NCT03618225	Post-thoracotomy Pain	Phase 4	Recruiting	January 1, 2019	Egypt ... 展开 >> National Cancer Institute, Cairo University Recruiting Cairo, Egypt Contact: Ekramy Mansour, MD 00201224642810 ekrameymansoure@yahoo.com 收起 <<
NCT01558700	Osteoarthritis	Phase 4	Completed	-	United States, Illinois ... 展开 >> Northwestern University Feinberg School of Medicine Chicago, Illinois, United States, 60611 收起 <<
NCT01552057	Fibromyalgia	Phase 3	Completed	-	Japan ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Miyagi, Japan, 982-0032 收起 <<
NCT01451606	Pelvis Pain Chronic	Phase 4	Terminated(Adequate recruitmen... 展开 >>t was not achieved in the time frame allowed.) 收起 <<	-	United States, Maryland ... 展开 >> University of Maryland, Baltimore Baltimore, Maryland, United States, 21201 收起 <<
NCT01931475	Osteoarthritis	Phase 3	Completed	-	China ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China, 100029 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bengbu, China, 233004 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changchun, China, 130033 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changsha, China, 410013 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chengdu, China, 610041 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guang Zhou, China, 510515 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hefei, China, 230022 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pingxiang, China, 337055 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shanghai, China, 200433 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shenyang, China, 110016 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tianjin, China, 300052 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Zhuzhou, China, 412007 收起 <<
NCT02700711	Cocaine Use Disorder	Phase 1	Completed	-	United States, Kentucky ... 展开 >> University of Kentucky Medical Center Lexington, Kentucky, United States, 40536 收起 <<
NCT03037073	Postoperative Myalgia	Phase 2 Phase 3	Completed	-	Egypt ... 展开 >> Assiut university hospital Assiut, Egypt, 71515 收起 <<
NCT00961298	Irritable Bowel Syndrome ... 展开 >> Generalized Anxiety Disorder 收起 <<	Phase 4	Completed	-	-
NCT00961298	-		Completed	-	-
NCT01855919	-		Completed	-	-
NCT01074151	-		Recruiting	December 2020	United States, North Carolina ... 展开 >> The Cymbalta Pregnancy Registry Call Center Recruiting Wilmington, North Carolina, United States, 28405 Contact 910-509-4700 Principal Investigator: Vikki Brown 收起 <<
NCT01552057	-		Completed	-	-
NCT03315793	Depressive Disorder	Phase 3	Recruiting	February 4, 2020	Japan ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting Kobe, Hyogo, Japan, 651-0086 Contact: Eli Lilly and Company 收起 <<
NCT03038867	Infertility, Male ... 展开 >> Depression 收起 <<	Phase 4	Recruiting	December 31, 2018	United States, New York ... 展开 >> Weill Cornell Medicine Recruiting New York, New York, United States, 10065 Contact: Adaobi Onunkwo 646-962-8311 ado2007@med.cornell.edu Contact: Ryan Flannigan, MD 212-746-5470 ryf9003@med.cornell.edu 收起 <<
NCT00889369	Major Depressive Disorder	Phase 4	Unknown	June 2012	Canada, Ontario ... 展开 >> Women's Health Concerns Clinic Recruiting Hamilton, Ontario, Canada, L8P 3B6 Contact: Stefanie M Attard 905-522-1155 ext 32048 sattard@stjoes.ca Principal Investigator: Claudio N Soares, MD, PhD Sub-Investigator: Benicio N Frey, MD, PhD Sub-Investigator: Geoffrey Hall, PhD Sub-Investigator: Meir Steiner, MD, PhD 收起 <<
NCT02535000	Intervertebral Disc Degenerati... 展开 >>on 收起 <<	Phase 4	Unknown	October 2016	-
NCT00471315	Sphincter of Oddi Dysfunction	Phase 3	Completed	-	United States, South Carolina ... 展开 >> Digestive Disease Center, Medical University of South Carolina Charleston, South Carolina, United States, 29425 收起 <<
NCT01931475	-		Completed	-	-
NCT02005601	Total Knee Arthroplasty	Phase 4	Completed	-	United States, New York ... 展开 >> Hospital for Special Surgery New York, New York, United States, 10021 收起 <<
NCT01914666	-		Completed	-	-
NCT02005601	-		Completed	-	-
NCT03729284	Healthy	Phase 4	Not yet recruiting	May 5, 2019	-
NCT03487211	Fibromyalgia	Phase 3	Recruiting	February 13, 2019	Pakistan ... 展开 >> Pakistan Institute of Medical Sciences Recruiting Islamabad, Islamabad Capital Territory, Pakistan, 44000 Contact: Rauf Niazi, MRCP, FRCP +923008544122 niazi62@hotmail.com 收起 <<
NCT01117857	Depression Me... 展开 >>nopause Vasomotor Symptoms 收起 <<	Phase 4	Completed	-	United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 收起 <<
NCT01269866	Systemic Lupus Erythematosus	Not Applicable	Completed	-	United States, New York ... 展开 >> Brain Resource Center New york, New York, United States, 10023 收起 <<
NCT00471315	-		Completed	-	-
NCT02291367	Healthy	Phase 1	Completed	-	India ... 展开 >> BA Research India Ltd Ahmedabad, Gujrat, India, 380 054 收起 <<
NCT02335346	-		Completed	-	-
NCT01852383	Depression Dy... 展开 >>sthymic Disorder 收起 <<	Phase 4	Completed	-	United States, New York ... 展开 >> New York State Psychiatric Institute New York, New York, United States, 10032 收起 <<
NCT02335346	Osteoarthritis of the Knee	Phase 3	Completed	-	Japan ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kobe, Japan, 650-0046 收起 <<
NCT01852383	-		Completed	-	-
NCT02600247	Osteoarthritis	Not Applicable	Unknown	November 2016	-
NCT01914666	Back Pain Lower Back Chronic	Phase 3	Completed	-	Japan ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Saitama, Japan, 330-0063 收起 <<
NCT03121573	Major Depressive Disorder	Not Applicable	Completed	-	-
NCT02291341	Healthy	Phase 1	Completed	-	India ... 展开 >> BA Research India Ltd Ahmedabad, Gujrat, India, 380 054 收起 <<
NCT01754493	-		Completed	-	-
NCT01117857	-		Completed	-	-
NCT01363284	Diabetes Pain... 展开 >>ful Neuropathy 收起 <<	Not Applicable	Completed	-	Israel ... 展开 >> Rambam Medical center Haifa, Israel 收起 <<
NCT01754493	Major Depression ... 展开 >> Irritable Bowel Syndrome 收起 <<	Phase 4	Completed	-	United States, New York ... 展开 >> New York State Psychiatric Institute, 1051 Riverside Drive New York, New York, United States, 10032 收起 <<
NCT01223001	Traumatic Brain Injury ... 展开 >> Depression 收起 <<	Phase 2	Terminated(Most potential subj... 展开 >>ects had already been prescribed Cymbalta.) 收起 <<	-	United States, Indiana ... 展开 >> Rehabilitation Hospital of Indiana Indianapolis, Indiana, United States, 46254 收起 <<
NCT01028352	-		Completed	-	-
NCT02351440	Quality of Recovery ... 展开 >> Gynecologic Surgery Laparoscopy 收起 <<	Phase 4	Withdrawn	-	United States, Illinois ... 展开 >> Prentice Womens Hospital Chicago, Illinois, United States, 60611 收起 <<
NCT01223001	-		Terminated(Most potential subj... 展开 >>ects had already been prescribed Cymbalta.) 收起 <<	-	-
NCT03350334	Laparoscopic Hysterectomy ... 展开 >> Postoperative Recovery Postoperative Pain 收起 <<	Not Applicable	Completed	-	Turkey ... 展开 >> Acibadem Maslak Hospital Sariyer, Istanbul, Turkey, 34457 收起 <<
NCT03395353	Depressive Disorder	Phase 3	Recruiting	March 31, 2021	Japan ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting Kobe, Hyogo, Japan, 651-0086 收起 <<
NCT01028352	Breast Cancer	Not Applicable	Completed	-	United States, Michigan ... 展开 >> University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109-0944 收起 <<
NCT01912612	Pain	Phase 2	Recruiting	March 2023	United States, Utah ... 展开 >> Huntsman Cancer Institute Recruiting Salt Lake City, Utah, United States, 84112 Contact: Amanda Behunin 801-587-4323 amanda.behunin@hci.utah.edu Principal Investigator: Norah L Henry, MD, PhD 收起 <<
NCT03249558	Chronic Low Back Pain ... 展开 >> Chronic Neck Pain 收起 <<	Phase 4	Recruiting	January 2021	United States, Massachusetts ... 展开 >> Center for Translational Pain Research Recruiting Boston, Massachusetts, United States, 02114 Contact: Sarah Roth, BS 617-724-6102 sroth3@mgh.harvard.edu Principal Investigator: Jianren Mao, M.D., Ph.D. 收起 <<
NCT02846701	Neuropathic Pain	Phase 4	Unknown	August 2017	-
NCT02934035	-		Unknown	September 2017	-
NCT00564278	Depression	Not Applicable	Completed	-	United States, New York ... 展开 >> New York State Psychiatric Institute, 1051 Riverside Drive New York, New York, United States, 10032 收起 <<
NCT01469377	Major Depressive Disorder	Phase 2	Completed	-	-
NCT01469377	-		Completed	-	-
NCT00564278	-		Completed	-	-
NCT01944657	1. Major Depressive Disorder	Not Applicable	Withdrawn(unable to enroll sub... 展开 >>jects) 收起 <<	December 2015	United States, Maryland ... 展开 >> Sheppard Pratt Health System Towson, Maryland, United States, 21204 收起 <<
NCT02400346	Major Depression Disorder	Phase 3	Completed	-	-
NCT01916824	Major Depressive Disorder ... 展开 >> Healthy Controls 收起 <<	Phase 4	Completed	-	United States, Georgia ... 展开 >> Emory Mood and Anxiety Disorders Program Atlanta, Georgia, United States, 30322 收起 <<
NCT03610217	Scleroderma, Systemic ... 展开 >> Sclerosis, Systemic 收起 <<	Not Applicable	Not yet recruiting	October 2021	Canada, Ontario ... 展开 >> Saint Joseph's Health Care London Not yet recruiting London, Ontario, Canada, n6a 4v2 Contact: Janet E Pope, MD, MPH, FRCPSC 15196466332 Janet.Pope@sjhc.london.on.ca Contact: Andreu Fernandez-Codina 151964661023 doccodina@gmail.com 收起 <<
NCT01488266	Major Depressive Disorder	Not Applicable	Unknown	March 2013	Korea, Republic of ... 展开 >> Korean Univ Ansan Hospital; Bucheon St.Mary Hospital; DonggukUniv Gyeongju Hospital; Catholic University of Korea St. Paul's Hospital Seoul, Korea, Republic of Taiwan Chang Gung Memorial Hospital; Kaohsiung Medical University Chung-ho Memorial Hospital Taipei, Taiwan 收起 <<
NCT00386243	Low Back Pain ... 展开 >> Pain Pain, Intractable 收起 <<	Not Applicable	Completed	-	United States, Indiana ... 展开 >> Richard Roudebush VA Medical Center, Indianapolis Indianapolis, Indiana, United States, 46202-2884 收起 <<
NCT00386243	-		Completed	-	-
NCT00351910	Major Depressive Disorder	Phase 3	Completed	-	-
NCT02374567	Dementia Depr... 展开 >>ession Schizophrenia Psychosomatic Disorders Anxiety Disorders 收起 <<	Phase 3	Terminated	-	Germany ... 展开 >> Bezirkskrankenhaus Augsburg Augsburg, Germany Krankenhaus Hedwigshöhe Berlin, Germany Hannover Medical School Hannover, Germany, 30625 Asklepios Fachklinikum Lübben Lübben, Germany Asklepios Fachklinikum Teupitz Teupitz, Germany 收起 <<
NCT00118430	Pain Depressi... 展开 >>on 收起 <<	Phase 4	Completed	-	United States, Indiana ... 展开 >> Indiana University Medical Center Indianapolis, Indiana, United States, 46202 收起 <<
NCT00118430	-		Completed	-	-
NCT00810069	-		Completed	-	-
NCT02655354	Posttraumatic Stress Disorder ... 展开 >> Depression Alcohol-Related Disorders Suicidal Ideation Substance-Related Disorders Mild Cognitive Impairment Quality of Life Pain Wounds and Injury Brain Injuries Chronic Disease 收起 <<	Not Applicable	Recruiting	June 2019	-
NCT01838681	Major Depressive Disorder	Phase 3	Completed	-	-
NCT02578459	Pain Management ... 展开 >> Cancer Pain 收起 <<	Not Applicable	Unknown	September 2018	United States, Kansas ... 展开 >> Menorah Medical Center Recruiting Overland Park, Kansas, United States, 66209 Contact: Charlotte Peterson 816-276-4227 cpeterson@mehrresearchfoundation.com Principal Investigator: Daniel R Kloster, MD Sub-Investigator: Jaswinder Singh, MD 收起 <<
NCT01916824	-		Completed	-	-
NCT02400346	-		Completed	-	-
NCT01305707	Depression	Phase 4	Terminated(Difficulties in rec... 展开 >>ruiting) 收起 <<	-	Spain ... 展开 >> Hospital Universitari de Bellvitge Hospitalet de Llobregat, Barcelona, Spain, 08907 Corporació Sanitària Parc Tauli Sabadell, Barcelona, Spain, 08208 Hospital Universitari de Bellvitge, IDIBELL Barcelona, Spain, 08907 收起 <<
NCT00854100	Major Depressive Disorder	Phase 2	Completed	-	-
NCT02493868	Depressive Disorder, Treatment... 展开 >>-Resistant 收起 <<	Phase 3	Completed	-	-
NCT03090152	Osteoarthritis, Hip	Phase 4	Recruiting	December 31, 2018	United States, New York ... 展开 >> Hospital for Special Surgery Recruiting New York, New York, United States, 10021 Principal Investigator: Kethy Jules-Elysee, MD 收起 <<
NCT01838681	-		Completed	-	-
NCT00090584	Urinary Incontinence (UI)	Not Applicable	Completed	-	United States, Alabama ... 展开 >> University of Alabama Birmingham, Alabama, United States, 35233 United States, California University of California San Diego, California, United States, 92103 United States, Illinois Loyola University Medical Center Maywood, Illinois, United States, 60153 United States, Maryland University of Maryland Baltimore, Maryland, United States, 21201 United States, Michigan Oakwood Hospital and Medical Center Royal Oak, Michigan, United States, 48123 United States, Pennsylvania University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 United States, Texas University of Texas Southwestern Dallas, Texas, United States, 75390 University of Texas Health Sciences Center San Antonio, Texas, United States, 78229 United States, Utah University of Utah Salt Lake City, Utah, United States, 84132 收起 <<
NCT00090584	-		Completed	-	-
NCT02670161	Brain Tumors ... 展开 >>Epilepsy Migraine Mild Cognitive Impairment Concussion Multiple Sclerosis Neuropathy Parkinson's Restless Legs Syndrome Stroke 收起 <<	Phase 4	Enrolling by invitation	April 2020	-
NCT01943435	Lumbar Spinal Stenosis	Not Applicable	Completed	-	United States, Pennsylvania ... 展开 >> UPMC Shadyside Center for Integrative Medicine Pittsburgh, Pennsylvania, United States, 15232 收起 <<
NCT01943435	-		Completed	-	-
NCT01436175	Major Depressive Disorder	Phase 3	Terminated(SPD489 failed to de... 展开 >>monstrate a benefit as adjunctive treatment to antidepressants. Termination was not related to any new safety findings.) 收起 <<	-	-
NCT02058693	Major Depressive Disorder	Phase 4	Completed	-	United States, Illinois ... 展开 >> Rush University Medical Center Chicago, Illinois, United States, 60612 收起 <<
NCT01584765	-		Completed	-	-
NCT00678691	-		Completed	-	-
NCT02893371	-		Enrolling by invitation	June 2019	United States, New Mexico ... 展开 >> Christophe G Lambert Albuquerque, New Mexico, United States, 87131 收起 <<
NCT00678691	Fibromyalgia, Primary	Phase 4	Completed	-	United States, New York ... 展开 >> SUNY Upstate Medical University Syracuse, New York, United States, 13210 收起 <<
NCT01556152	Painful Diabetic Neuropathy	Phase 2	Withdrawn(Due to new scientifi... 展开 >>c evidence assessment, the study design was revised before the study started recruitment) 收起 <<	-	Germany ... 展开 >> Site 2 Mainz, Germany United Kingdom Site 1 Manchester, United Kingdom 收起 <<
NCT00742573	Major Depressive Disorder	Phase 2	Active, not recruiting	January 2019	United States, New York ... 展开 >> New York State Psychiatric Institute New York, New York, United States, 10032 收起 <<
NCT03634527	Chemotherapy-induced Periphera... 展开 >>l Neuropathy (CIPN) 收起 <<	Not Applicable	Recruiting	December 30, 2019	United States, Maryland ... 展开 >> Johns Hopkins Hospital Recruiting Baltimore, Maryland, United States, 21205 收起 <<
NCT01436149	Major Depressive Disorder	Phase 3	Completed	-	-
NCT01436175	-		Terminated(SPD489 failed to de... 展开 >>monstrate a benefit as adjunctive treatment to antidepressants. Termination was not related to any new safety findings.) 收起 <<	-	-
NCT01896349	Treatment Resistant Depression	Not Applicable	Unknown	November 2014	Brazil ... 展开 >> Federal University of Rio Grande do Sul / Hospital de Clínicas de Porto Alegre (HCPA) Recruiting Porto Alegre, RS, Brazil, 90035-003 Contact: Lívia H Souza, MD +55 5198658701 livia.hs@terra.com.br Contact: Marcelo PA Fleck, MD, PhD +55 51 33598294 mfleck.voy@terra.com.br Sub-Investigator: Lívia H Souza, MD Principal Investigator: Marcelo PA Fleck, MD, PhD Sub-Investigator: Marco Antonio K Caldieraro, MD, MSc Sub-Investigator: Lucas Spanemberg, MD Sub-Investigator: Edgar A Vares, MD 收起 <<
NCT01041495	Fibromyalgia ... 展开 >>Pain Sleep Fatigue 收起 <<	Phase 4	Unknown	March 2013	United States, New York ... 展开 >> SUNY Upstate Medical University Recruiting Syracuse, New York, United States, 13210 Contact: thomas l schwartz, md 315-464-3166 schwartt@upstate.edu Principal Investigator: Thomas L Schwartz, MD 收起 <<
NCT01436162	Major Depressive Disorder	Phase 3	Completed	-	-
NCT01436162	-		Completed	-	-
NCT01436149	-		Completed	-	-
NCT02883660	-		Completed	-	United States, Pennsylvania ... 展开 >> Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 收起 <<
NCT00938834	Fibromyalgia Pain	Not Applicable	Completed	-	Canada, Nova Scotia ... 展开 >> Pain Management Unit - CDHA Halifax, Nova Scotia, Canada 收起 <<
NCT03207828	Fibromyalgia ... 展开 >>Depression 收起 <<	Not Applicable	Recruiting	May 31, 2019	Chile ... 展开 >> Red Salud UC Christus Recruiting Santiago, Chile, Macul Contact: Josefina Durán, MA jgduran@uc.cl Contact: Matías González, PhD magonza@med.puc.cl 收起 <<
NCT01360866	Depressive Disorder ... 展开 >> Depression Depressive Disorder, Major Mood Disorders Mental Disorders 收起 <<	Phase 3	Completed	-	-
NCT01360866	-		Completed	-	-
NCT02711215	Major Depressive Disorder	Phase 4	Recruiting	March 2019	Austria ... 展开 >> Department of Psychiatry and Psychotherapy, Medical University of Vienna Recruiting Vienna, Austria, 1090 Contact: Rupert Lanzenberger, A/Prof. +43 40400 ext 35760 rupert.lanzenberger@meduniwien.ac.at Principal Investigator: Rupert Lanzenberger, A/Prof. MD 收起 <<
NCT02970526	-		Recruiting	September 2018	France ... 展开 >> CHU Clermont-Ferrand Recruiting Clermont-Ferrand, France, 63003 Contact: Patrick LACARIN 0473751195 placarin@chu-clermontferrand.fr Principal Investigator: Denis PEZET 收起 <<
NCT01796132	Depressive Disorder ... 展开 >> Lactation 收起 <<	Phase 4	Unknown	December 2018	France ... 展开 >> Service d'Obstétrique, Service de Néonatologie; Centre Hospitalier Universitaire Nancy Recruiting Nancy, Meurthe-et-Moselle, France Contact: Jean-Michel Hascoët, Prof MD jm.hascoet@maternite.chu-nancy.fr Principal Investigator: Jean-Michel Hascoët, Prof MD Sub-Investigator: Catherine Lamy, MD Service d'Obstétrique, Service de Néonatologie; Hospices civiles de Lyon (HCL) Recruiting Lyon, Rhône, France Contact: Olivier Claris, Prof MD olivier.claris@chu-lyon.fr Principal Investigator: Olivier Claris, Prof MD Sub-Investigator: Pascal Gaucherand, Prof MD Sub-Investigator: Etienne Beaufils, MD Sub-Investigator: Kim NGuyen, MD Switzerland Division de Pharmacologie Clinique, Service d'Obstétrique, Service de Néonatologie, Service de Pédopsychiatrie de liaison, Unité de Pharmacogénétique et Psychopharmacologie Clinique; Centre Hospitalier Universitaire Vaudois (CHUV) Recruiting Lausanne, Vaud, Switzerland Contact: Chantal Csajka, Prof PhD chantal.csajka@chuv.ch Principal Investigator: Chantal Csajka, Prof PhD Sub-Investigator: Alice Panchaud, PhD Sub-Investigator: Chin B Eap, Prof PhD Sub-Investigator: Jean-Francois Tolsa, Prof MD Sub-Investigator: Yvan Vial, MD MER Sub-Investigator: Myriam Bickle Graz, MD Sub-Investigator: Mathilde Morisod Harari, MD Sub-Investigator: Céline Fischer, MD Service d'Obstétrique, Service de Pédiatrie; Ensemble Hospitalier de la Côte (EHC) Recruiting Morges, Vaud, Switzerland Contact: Sylvie Rouiller, MD sylvie.rouiller@ehc.vd.ch Principal Investigator: Sylvie Rouiller, MD Service d'Obstétrique, Service du Développement et de la Croissance; Hopitaux Universitaires Genevois (HUG) Recruiting Geneva, Switzerland Contact: Manuella Epiney, MD manuella.epiney@hcuge.ch Principal Investigator: Manuella Epiney, MD Principal Investigator: Cristina Borradori Tolsa, MD 收起 <<
NCT00763724	-		Completed	-	-
NCT00817011	Depression An... 展开 >>tidepressant Drug Adverse Reaction 收起 <<	Not Applicable	Unknown	March 2018	Korea, Republic of ... 展开 >> Samsung Medical Center Recruiting Kangnam, Seoul, Korea, Republic of, 135-710 Contact: DohKwan Kim Principal Investigator: Doh Kwan Kim, ph.D, M.D. 收起 <<
NCT01369290	-		Unknown	October 2013	Canada, Ontario ... 展开 >> St. Joseph's Healthcare, Centre for Mountain Health Services Recruiting Hamilton, Ontario, Canada, L8N 3K7 Contact: Rose Marie Mueller, RN 905-522-1155 ext 36629 rmueller@stjoes.ca Principal Investigator: Gary M Hasey, MD 收起 <<
NCT03538691	Major Depressive Disorder	Phase 3	Recruiting	September 2022	-
NCT01764867	Major Depressive Disorder	Phase 4	Unknown	December 2014	China ... 展开 >> Shanghai Mental Health Center Recruiting Shanghai, China, 200030 Contact: Zhiguo Wu, M.D. 862134289888 ext 3528 wu_zhiguo@yahoo.com.cn Principal Investigator: Yiru Fang, Ph.D., M.D. 收起 <<
NCT02422186	Depressive Disorder, Treatment... 展开 >>-Resistant 收起 <<	Phase 3	Completed	-	-
NCT02977299	Treatment Resistant Major Depr... 展开 >>essive Disorder 收起 <<	Phase 4	Recruiting	January 2022	-
NCT02417064	Treatment-resistant Depression	Phase 3	Completed	-	-
NCT02497287	Treatment-resistant Depression	Phase 3	Completed	-	-
NCT02320240	-		Completed	-	Canada, Quebec ... 展开 >> Lady Davis Institute for Medical Research, Jewish General Hospital Montreal, Quebec, Canada, H3T1E2 收起 <<
NCT03434041	Depressive Disorder, Treatment... 展开 >>-Resistant 收起 <<	Phase 3	Recruiting	April 28, 2021	United States, Georgia ... 展开 >> Atlanta Center for Medical Research Recruiting Atlanta, Georgia, United States, 30331 United States, Louisiana Biomedical Research Foundation of Northwest Louisiana Recruiting Shreveport, Louisiana, United States, 71104-2136 United States, Maryland CBH Health Recruiting Gaithersburg, Maryland, United States, 20877 United States, Massachusetts Adams Clinical Trials, LLC Recruiting Watertown, Massachusetts, United States, 02472 United States, New York The Medical Research Network, LLC Recruiting New York, New York, United States, 10128 United States, Oklahoma IPS Research Company Recruiting Oklahoma City, Oklahoma, United States, 73103 China Beijing Anding Hospital of Capital Medical University Recruiting Beijing, China, 100088Chile Beijing HuiLong Guan Hospital Recruiting Beijing, China, 100096 Peking University Sixth Hospital Recruiting Beijing, China, 100191 The Second People's Hospital of Hunan Province / Brian Hospital of Hunan Province Recruiting Changsha, China, 410007 The second Xiangya Hospital of Central South University Recruiting Changsha, China West China Hospital, Sichuan University Not yet recruiting Chengdu, China, 610041 Chongqing Mental Health Center Recruiting Chongqing, China, 401147 the 3rd Affiliated Hospital,Sun Yansen University Recruiting Guangzhou, China, 510000 Guangdong General Hospital Recruiting Guangzhou, China, 510100 The First Affiliated Hospital of Jinan Medical University / Guangzhou Overseas Chinese Hospital Withdrawn Guangzhou, China, 510630 Hangzhou Seventh People's Hospital Recruiting Hangzhou, China, 310000 The Second Affiliated Hospital of Zhejiang University Recruiting Hangzhou, China, 310009 First Affiliated Hospital of Kunming Medical Unversity Not yet recruiting Kunming City, China, 650032 Nanjing Brain Hospital Affilicated to Nanjing Medical University Recruiting Nanjing, China, 210000 Shanghai Mental Health Center Withdrawn Shanghai, China, 200030 The First Hospital of Hebei Medical University Recruiting Shijiazhuang, China, 050031 Tianjin Anding Hospital Recruiting Tianjin, China, 300222 Renmin Hospital of Wuhan Universtiy / Hubei General Hospital Recruiting Wuhan, China, 430060 First Affiliated Hospital, Xi'an Jiaotong University Recruiting Xi'An, China, 710061 Xi'an Mental Health Center Recruiting Xi'An, China, 710061 收起 <<
NCT00725101	-		Completed	-	-
NCT00200902	Depression	Phase 4	Suspended	June 2009	United States, California ... 展开 >> UCLA Laboratory of Brain, Behavior, and Pharmacology Los Angeles, California, United States, 90024 收起 <<
NCT01288079	Major Depressive Disorder	Phase 2	Terminated	-	-
NCT03054220	Healthy	Not Applicable	Active, not recruiting	July 2017	-
NCT02418585	Treatment-resistant Depression	Phase 3	Completed	-	-
NCT00725101	-		Completed	-	-
NCT01579279	Diabetic Neuropathic Pain	Phase 2	Terminated(Study Stopped)	-	United States, California ... 展开 >> Site Reference ID/Investigator# 62887 Anaheim, California, United States, 92801 Site Reference ID/Investigator# 62824 Walnut Creek, California, United States, 94598 United States, Connecticut Site Reference ID/Investigator# 63710 Milford, Connecticut, United States, 06460 United States, Florida Site Reference ID/Investigator# 62884 DeLand, Florida, United States, 32720 Site Reference ID/Investigator# 62826 Orlando, Florida, United States, 32806 United States, Massachusetts Site Reference ID/Investigator# 63703 Brockton, Massachusetts, United States, 02301 United States, Mississippi Site Reference ID/Investigator# 73913 Olive Branch, Mississippi, United States, 38654 United States, Texas Site Reference ID/Investigator# 62886 Dallas, Texas, United States, 75231 收起 <<
NCT00599911	Major Depressive Disorder	Phase 2	Completed	-	-
NCT01288079	-		Terminated	-	-
NCT00321490	Major Depressive Disorder	Phase 3	Completed	-	-
NCT02672202	Post-operative Chronic Pain	Not Applicable	Terminated(Recruitment rate wa... 展开 >>s slow so we could not complete the study.) 收起 <<	-	-
NCT03325959	Fibromyalgia ... 展开 >>Hyperbaric Oxygen 收起 <<	Not Applicable	Not yet recruiting	November 1, 2019	Israel ... 展开 >> Assaf-Harofeh Medical Center Zerifin, Israel, 70300 收起 <<
NCT01377038	Osteoarthritis ... 展开 >> Chronic Pain 收起 <<	Not Applicable	Withdrawn(Funding)	July 2015	United States, Michigan ... 展开 >> University of Michigan Ann Arbor, Michigan, United States, 48109 收起 <<
NCT00837941	Painful Diabetic Neuropathy	Phase 2	Withdrawn	September 2009	-
NCT00561509	-		Completed	-	-
NCT01470352	Migraine	Not Applicable	Recruiting	September 2018	Israel ... 展开 >> Rambam health care campus Recruiting Haifa, Israel Contact: David Yarnitsky 9728542605 d_yarnitsky@rambam.health.gov.il 收起 <<
NCT02260388	Cryptogenic Sensory Polyneurop... 展开 >>athy 收起 <<	Phase 4	Completed	-	-
NCT02260388	-		Completed	-	-
NCT02476136	-		Unknown	December 2016	-
NCT00177671	Depression De... 展开 >>mentia 收起 <<	Phase 4	Completed	-	United States, Pennsylvania ... 展开 >> University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States, 15213 收起 <<
NCT01369095	Depression	Phase 2	Completed	-	-
NCT01057329	-		Recruiting	February 2018	Austria ... 展开 >> Medical University of Vienna Recruiting Vienna, Austria, A-1090 Contact: Andreas Karwautz, Prof 0043-1-40400 ext 3057 andreas.karwautz@meduniwien.ac.at Contact: Julia Huemer, MD 0043-1-40400- ext 2747 julia.huemer@meduniwien.ac.at Sub-Investigator: Julia Huemer, MD 收起 <<
NCT03148522	Diagnosis and Treatment of Dep... 展开 >>ression 收起 <<	Phase 4	Not yet recruiting	December 30, 2021	-
NCT03321006	Hearing Loss ... 展开 >>Depression 收起 <<	Phase 4	Recruiting	August 15, 2019	United States, New York ... 展开 >> New York State Psychiatric Institute Recruiting New York, New York, United States, 10032 Contact: Veronika Bailey, MA 646-774-8655 vbailey@nyspi.columbia.edu Principal Investigator: Bret R Rutherford, MD 收起 <<
NCT00177671	-		Completed	-	-
NCT02869035	Major Depressive Disorder	Phase 1	Recruiting	July 2019	Denmark ... 展开 >> Neurobiology Research Unit, Rigshospitalet Recruiting Copenhagen, Denmark, 2100 Contact: Gitte M Knudsen, DMSc +45 35456720 gmk@nru.dk 收起 <<
NCT01145755	Major Depressive Disorder	Phase 2	Terminated	-	United States, California ... 展开 >> Research Site Garden Grove, California, United States Research Site San Diego, California, United States United States, Florida Research Site Jacksonville, Florida, United States United States, Georgia Research Site Atlanta, Georgia, United States United States, Maryland Research Site Rockville, Maryland, United States United States, Massachusetts Research Site Boston, Massachusetts, United States United States, New York Research Site Cedarhurst, New York, United States Research Site Rochester, New York, United States United States, Oregon Research Site Portland, Oregon, United States United States, Tennessee Research Site Memphis, Tennessee, United States United States, Texas Research Site Friendswood, Texas, United States United States, Washington Research Site Bellevue, Washington, United States Research Site Seattle, Washington, United States 收起 <<
NCT03623711	Major Depressive Disorder ... 展开 >> Depression, Unipolar 收起 <<	Early Phase 1	Recruiting	December 31, 2020	China, Yunnan ... 展开 >> The First Affiliated Hospital of Kunming Medical University Recruiting Kunming, Yunnan, China, 650032 Contact: Yuqi Cheng, PhD +86-0871-65324888 yuqicheng@126.com Contact: Yuqi Cheng 13888122013 yuqicheng@126.com 收起 <<
NCT00384033	-		Completed	-	-
NCT00384033	Depressive Disorder, Major	Phase 3	Completed	-	United States, California ... 展开 >> Pfizer Investigational Site Beverly Hills, California, United States, 90210 Pfizer Investigational Site Burbank, California, United States, 91506 Pfizer Investigational Site Encino, California, United States, 91316 Pfizer Investigational Site Los Alamitos, California, United States, 90720 Pfizer Investigational Site Newport Beach, California, United States, 92660 Pfizer Investigational Site Northridge, California, United States, 91324 Pfizer Investigational Site Orange, California, United States, 92868 Pfizer Investigational Site Pasadena, California, United States, 91105 Pfizer Investigational Site Upland, California, United States, 91786 United States, Florida Pfizer Investigational Site South Miami, Florida, United States, 33143 Pfizer Investigational Site St. Petersburg, Florida, United States, 33702 United States, Illinois Pfizer Investigational Site Edwardsville, Illinois, United States, 62025 United States, Michigan Pfizer Investigational Site Farmington Hills, Michigan, United States, 48336 Pfizer Investigational Site Flint, Michigan, United States, 48507 Pfizer Investigational Site Okemos, Michigan, United States, 48864 United States, New Jersey Pfizer Investigational Site Clementon, New Jersey, United States, 08021 United States, Ohio Pfizer Investigational Site Dayton, Ohio, United States, 45408 United States, Oregon Pfizer Investigational Site Portland, Oregon, United States, 97210 United States, Pennsylvania Pfizer Investigational Site Philadelphia, Pennsylvania, United States, 19149 United States, Utah Pfizer Investigational Site Salt Lake City, Utah, United States, 84107 United States, Washington Pfizer Investigational Site Seattle, Washington, United States, 98104 United States, Wisconsin Pfizer Investigational Site Brown Deer, Wisconsin, United States, 53223 收起 <<
NCT03276689	Neuropathic Pain	Not Applicable	Not yet recruiting	September 30, 2020	-
NCT01145755	-		Terminated	-	-
NCT00730691	Generalized Anxiety Disorder	Phase 3	Completed	-	-
NCT01973283	Major Depressive Disorder ... 展开 >> Dysthymic Disorder Depressive Disorder, NOS 收起 <<	Phase 4	Recruiting	July 2019	United States, New York ... 展开 >> New York State Psychiatric Institute Recruiting New York, New York, United States, 10032 Contact: Kiley Cappetta 646-774-8652 kiley.cappetta@nyspi.columbia.edu Principal Investigator: Patrick Brown, PhD 收起 <<
NCT01359514	Pain	Not Applicable	Completed	-	Israel ... 展开 >> Rambam Medical center Haifa, Israel 收起 <<
NCT00672620	Major Depressive Disorder	Phase 3	Completed	-	-
NCT00730691	-		Completed	-	-
NCT00479726	Major Depressive Disorder	Phase 4	Completed	-	United States, Indiana ... 展开 >> For additional information regarding investigative sites for this trial,contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM - 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Indianapolis, Indiana, United States 收起 <<
NCT00596986	Chronic Depression	Not Applicable	Unknown	-	Germany ... 展开 >> Charité Universitätsmedizin Berlin, Germany, 14050 收起 <<
NCT00810069	Major Depressive Disorder	Phase 4	Completed	-	-
NCT01078870	Schizophrenia	Phase 4	Unknown	January 2011	Taiwan ... 展开 >> National Taiwan University Hospital Taipei, Taiwan, 100 收起 <<
NCT00660751	Healthy	Not Applicable	Completed	-	Israel ... 展开 >> Rambam Health Care Campus Haifa, Israel, 31096 收起 <<
NCT00360399	Depression	Not Applicable	Completed	-	United States, Georgia ... 展开 >> Emory University Mood and Anxiety Disorders Program Atlanta, Georgia, United States, 30306 Emory University School of Medicine Atlanta, Georgia, United States, 30322 收起 <<
NCT02857244	Parkinson's Disease	Phase 2	Withdrawn(Site did not obtain ... 展开 >>LIRB approval due to medication usage.) 收起 <<	November 2017	United States, Illinois ... 展开 >> University of Chicago Medical Center Chicago, Illinois, United States, 60637 收起 <<
NCT01309945	Depression	Phase 2	Completed	-	-
NCT00507936	Diabetic Neuralgia ... 展开 >> Diabetic Neuropathies Diabetic Neuropathy, Painful Diabetic Polyneuropathy Neuralgia, Diabetic 收起 <<	Phase 2	Completed	-	-
NCT00672620	-		Completed	-	-
NCT00360399	-		Completed	-	-
NCT00149110	Major Depression	Not Applicable	Completed	-	Denmark ... 展开 >> Psychiatric Research Unit, Hilleroed Hospital Hilleroed, Denmark, 3400 收起 <<
NCT01404871	Obsessive Compulsive Disorder	Not Applicable	Completed	-	Canada, Ontario ... 展开 >> Sunnybrook Health Sciences Centre Toronto, Ontario, Canada, M4N 3M5 The Centre for Addiction and Mental Health Toronto, Ontario, Canada, M5T 1R8 收起 <<
NCT01504178	Parkinson's Disease	Phase 3	Completed	-	France ... 展开 >> CIC, Purpan Hospital Toulouse, France, 31059 收起 <<
NCT01268631	Fibromyalgia	Not Applicable	Unknown	January 2013	Israel ... 展开 >> Rheumatology Institute, Tel Aviv Sourasky Medical Center Not yet recruiting Tel Aviv, Israel Contact: Jacob Ablin, MD 972-3-6973668 Principal Investigator: Jacob N Ablin, MD 收起 <<
NCT03249311	None (i.e. Healthy Volunteers)	Phase 4	Recruiting	January 31, 2020	Canada, Ontario ... 展开 >> Institute of Mental Health Research, Royal Ottawa Mental Health Centre Recruiting Ottawa, Ontario, Canada, K1Z 7K4 Contact: Holly English, RN 613-722-6521 ext 6405 holly.english@theroyal.ca Contact: Wendy Fusee, RN 613-722-6521 ext 7828 wendy.fusee@theroyal.ca Principal Investigator: Pierre Blier, MD 收起 <<
NCT00058968	Diabetic Neuropathy, Painful	Phase 3	Completed	-	United States, Florida ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLilly (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pembroke Pines, Florida, United States 收起 <<
NCT03068247	Major Depressive Disorder	Phase 3	Not yet recruiting	May 2021	United States, Utah ... 展开 >> University of Utah Not yet recruiting Salt Lake City, Utah, United States, 84112 Contact: Andrea White 801-742-1517 andrea.white@hsc.utah.edu Contact: Allison Bustamante 8017421517 utahneuroimagelab@gmail.com 收起 <<
NCT01564862	-		Completed	-	-
NCT02020122	Pain	Not Applicable	Completed	-	Israel ... 展开 >> Rambam Health Care Campus Haifa, Israel 收起 <<
NCT01688570	Stroke	Early Phase 1	Completed	-	United States, Wisconsin ... 展开 >> Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53201 收起 <<
NCT00603265	Peripheral Neuropathy ... 展开 >> Neuropathic Pain 收起 <<	Phase 2	Completed	-	-
NCT00603265	-		Completed	-	-
NCT00635219	Major Depressive Disorder	Phase 3	Completed	-	-
NCT00863057	-		Completed	-	-
NCT00388414	Low Back Pain	Not Applicable	Completed	-	United States, California ... 展开 >> Stanford University School of Medicine Stanford, California, United States, 94305 收起 <<
NCT01564862	Depressive Disorder, Major	Phase 2	Completed	-	-
NCT00388414	-		Completed	-	-
NCT01153009	Depressive Disorder, Major	Phase 3	Completed	-	-
NCT00863057	HIV Infections ... 展开 >> Peripheral Neuropathy 收起 <<	Phase 2	Completed	-	United States, California ... 展开 >> Ucsd, Avrc Crs San Diego, California, United States, 92103 Harbor-UCLA Med. Ctr. CRS Torrance, California, United States, 90502 United States, Colorado University of Colorado Hospital CRS Aurora, Colorado, United States, 80045 United States, Illinois Northwestern University CRS Chicago, Illinois, United States, 60611 United States, Massachusetts Massachusetts General Hospital ACTG CRS Boston, Massachusetts, United States, 02114 United States, Missouri Washington U CRS Saint Louis, Missouri, United States, 63110 United States, Ohio MetroHealth CRS Cleveland, Ohio, United States, 44109 United States, Texas Houston AIDS Research Team CRS Houston, Texas, United States, 77030 收起 <<
NCT00849693	Major Depressive Disorder	Phase 3	Completed	-	-
NCT01153009	-		Completed	-	-
NCT00399022	OCD	Not Applicable	Withdrawn(Funding was not reci... 展开 >>eved) 收起 <<	-	Israel ... 展开 >> Chaim Sheba Medical Center Ramat-Gan, Israel, 52621 收起 <<
NCT00337012	-		Unknown	-	Germany ... 展开 >> University Clinic Bonn Recruiting Bonn, NRW, Germany, 53105 Contact: Christian G Schütz +49 228 2879664 收起 <<
NCT01650740	Major Depressive Disorder	Not Applicable	Terminated(Poor recruitment re... 展开 >>sults.) 收起 <<	-	Canada, Ontario ... 展开 >> Sunnybook Health Sciences Centre Toronto, Ontario, Canada, M4N 3M5 收起 <<
NCT00635219	-		Completed	-	-
NCT01443520	Healthy	Phase 4	Completed	-	Finland ... 展开 >> Department of Anaesthesiology, Intensive Care, Emergency Care and Pain Medicine, Turku University and Turku University Hospital Turku, Finland 收起 <<
NCT00849693	-		Completed	-	-

靶点	5-HT
描述	Duloxetine is a serotonin-norepinephrine reuptake inhibitor with Ki of 4.6 nM, used for treatment of major depressive disorder and generalized anxiety disorder (GAD).

CAS号	116539-59-4
分子式	C₁₈H₁₉NOS
分子量	297.415

别名	(S)-Duloxetine;LY248686
运输	蓝冰

度洛西汀 /Duloxetine 98+%

Duloxetine 纯度/质量文件产品仅供科研

全球学术期刊中引用的产品

Duloxetine 质控信息

Duloxetine 生物活性

Duloxetine 临床研究

Duloxetine 参考文献

Duloxetine 实验方案

Duloxetine 技术信息

最近浏览的产品

大规格询价

摩尔计算器

靶点

总药量计算器

工作液计算器

细胞研究

临床研究

确认信息

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

度洛西汀 /Duloxetine 98+%

Duloxetine 纯度/质量文件 产品仅供科研

全球学术期刊中引用的产品

Duloxetine 质控信息

Duloxetine 生物活性

Duloxetine 临床研究

Duloxetine 参考文献

Duloxetine 实验方案

Duloxetine 技术信息

最近浏览的产品

大规格询价

摩尔计算器

靶点

总药量计算器

工作液计算器

细胞研究

临床研究

确认信息

请登录您的专属账户

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

Duloxetine 纯度/质量文件产品仅供科研